GT
CVS icon

Glenview Trust’s CVS Health CVS Stock Holding History

Glenview Trust’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$553K Sell
7,703
-679
-8% -$52.3K 0.01% 351
2025
Q4 		$665K Sell
8,382
-1,201
-13% -$94.7K 0.01% 331
2025
Q3 		$722K Sell
9,583
-174
-2% -$11.9K 0.01% 332
2025
Q2 		$673K Sell
9,757
-10,028
-51% -$658K 0.01% 332
2025
Q1 		$1.34M Sell
19,785
-11,000
-36% -$658K 0.03% 239
2024
Q4 		$1.38M Sell
30,785
-126,730
-80% -$7.11M 0.03% 242
2024
Q3 		$9.9M Sell
157,515
-33,050
-17% -$1.93M 0.19% 104
2024
Q2 		$11.3M Sell
190,565
-822
-0.4% -$51.4K 0.23% 96
2024
Q1 		$15.3M Buy
191,387
+35,901
+23% +$2.74M 0.33% 77
2023
Q4 		$12.3M Buy
155,486
+40,151
+35% +$2.86M 0.3% 84
2023
Q3 		$8.05M Buy
115,335
+32,024
+38% +$2.27M 0.22% 102
2023
Q2 		$5.76M Buy
83,311
+3,230
+4% +$230K 0.16% 110
2023
Q1 		$5.95M Buy
80,081
+3,541
+5% +$297K 0.18% 104
2022
Q4 		$7.13M Buy
76,540
+10,649
+16% +$1.03M 0.24% 98
2022
Q3 		$6.28M Buy
65,891
+15,523
+31% +$1.54M 0.24% 97
2022
Q2 		$4.67M Buy
50,368
+30,495
+153% +$2.98M 0.17% 104
2022
Q1 		$2.01M Buy
19,873
+135
+0.7% +$14.2K 0.07% 159
2021
Q4 		$2.04M Buy
19,738
+7,125
+56% +$658K 0.07% 156
2021
Q3 		$1.07M Buy
12,613
+1,987
+19% +$166K 0.04% 189
2021
Q2 		$887K Buy
10,626
+731
+7% +$59.9K 0.03% 199
2021
Q1 		$745K Buy
9,895
+4,285
+76% +$312K 0.03% 211
2020
Q4 		$383K Buy
5,610
+244
+5% +$15.9K 0.02% 268
2020
Q3 		$313K Sell
5,366
-547
-9% -$34K 0.02% 273
2020
Q2 		$384K Sell
5,913
-1,007
-15% -$63.4K 0.02% 249
2020
Q1 		$411K Sell
6,920
-250
-3% -$16.7K 0.03% 226
2019
Q4 		$533K Sell
7,170
-341
-5% -$23.9K 0.03% 228
2019
Q3 		$474K Buy
7,511
+294
+4% +$17.4K 0.03% 242
2019
Q2 		$393K Sell
7,217
-3,360
-32% -$181K 0.02% 256
2019
Q1 		$571K Sell
10,577
-2,795
-21% -$173K 0.04% 220
2018
Q4 		$876K Buy
13,372
+1,976
+17% +$148K 0.06% 185
2018
Q3 		$897K Sell
11,396
-1,184
-9% -$84.6K 0.06% 188
2018
Q2 		$810K Sell
12,580
-28,946
-70% -$1.91M 0.06% 173
2018
Q1 		$2.58M Sell
41,526
-26,166
-39% -$1.88M 0.18% 117
2017
Q4 		$4.91M Sell
67,692
-34,909
-34% -$2.54M 0.34% 87
2017
Q3 		$8.34M Buy
102,601
+2,187
+2% +$173K 0.61% 54
2017
Q2 		$8.08M Buy
100,414
+8,476
+9% +$669K 0.63% 55
2017
Q1 		$7.22M Buy
91,938
+27,134
+42% +$2.17M 0.57% 63
2016
Q4 		$5.11M Buy
+64,804
New +$5.24M 0.42% 78
2015
Q4 		$3.78M Buy
+38,623
New +$3.78M 0.39% 70
2014
Q4 		$2.08M Buy
+21,613
New +$1.9M 0.22% 83
2013
Q4 		$834K Buy
+11,651
New +$749K 0.1% 110

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Glenview Trust's CVS Position: Q1 2026 in Review

Glenview Trust reduced its CVS Health (CVS) stake by 8.1% in Q1 2026, selling an estimated $52.3K and leaving 7,703 shares worth $553K. The position accounts for 0.01% of the portfolio, ranked #351.

Glenview Trust first reported a position in CVS in Q4 2013 and has held it in 41 quarters since. The position peaked at $15.3M in Q1 2024. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Glenview Trust held 7,703 shares of CVS Health worth $553K as of Q1 2026.
  • Glenview Trust sold 679 CVS Health shares in Q1 2026, an estimated $52.3K.
  • CVS Health made up 0.01% of Glenview Trust's portfolio in Q1 2026, its #351 holding.
  • Glenview Trust first reported a position in CVS Health in Q4 2013 and has held it in 41 quarters since.
  • Glenview Trust's CVS Health position peaked at $15.3M in Q1 2024.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Glenview Trust's 13F filing for Q1 2026, filed 8 May 2026.